Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report : Anti-Cancer Drugs

Journal Logo

Case Reports

Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report

Wu, Chao,*; Fan, Mengjiao,*; Hu, Yi

Author Information
Anti-Cancer Drugs 33(1):p e734-e737, January 2022. | DOI: 10.1097/CAD.0000000000001160

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid